Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VIVONICS INC
Awarding agency: Department of Defense / Department of the Navy
Funding agency: Department of Defense / Department of the Navy
Period of performance: 2019-06-14 to 2023-02-28
Current total value of award: $1492783
Description: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION C OF THE SOW TO REFLECT THE NEW GUIDANCE FROM THE FDA REGARDING REQUIRED CHANGES IN THE SAFETY AND EFFICACY PHASE II TRIALS.